Chinese Influenza Weekly Report

Similar documents
Chinese Influenza Weekly Report

Chinese Influenza Weekly Report

Chinese Influenza Weekly Report

Chinese Influenza Weekly Report

Chinese Influenza Weekly Report

Chinese Influenza Weekly Report

Surveillance Overview

RESPIRATORY VIRUS SURVEILLANCE REPORT

Current Vaccines: Progress & Challenges. Influenza Vaccine what are the challenges?

Influenza Surveillance Summary: Denton County Hospitals and Providers 17.51% 15.95% 10.94% 7.41% 9.01% 8.08%

Influenza Global Epidemiologic Update

MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH WEEKLY INFLUENZA UPDATE January 26, 2018

Influenza Situation Update

Seasonal Influenza Report

Summary. Week 11/2017 (13 19 March 2017) Season overview

Week 11: March 11 to March 17, 2018

Week 15: April 8 to April 14, 2018

Seasonal Influenza Report

Questions and Answers

Influenza Surveillance in Ireland Weekly Report Influenza Week (11 th 17 th December 2017)

Influenza Surveillance in Ireland Weekly Report Influenza Week (22 nd 28 th January 2018)

Seasonal Influenza Report

Influenza Update N 159

Influenza Situation Update

Summary. Week 13/2018 (26 31 March 2018) season overview

Influenza Update N 157

Summary. Week 15/2018 (9 15 April 2018) season overview

Western Pacific Regional Office of the World Health Organization

Influenza Situation Update

REPORT. Early risk assessment: What to expect of the 2017/18 influenza season in Norway


Western Pacific Regional Office of the World Health Organization.

Influenza and other Respiratory Viruses Update

Summary: Increasing Activity

Summary. Week 4/2018 (22 28 January 2018) season overview

Influenza Surveillance in Ireland Weekly Report Influenza Week (12 th 18 th March 2018)

NC IMMUNIZATION COALITION FLU THEN AND NOW NC DHHS COMMUNICABLE DISEASE BRANCH ANITA VALIANI, MPH AUGUST 1, 2018

Influenza surveillance summary

November 5 to 11, 2017 (Week 45)

Bi-weekly Influenza Situation Update

Influenza Surveillance in Ireland Weekly Report Influenza Weeks 13 & (26 th March 8 th April 2018)

Summary: Low activity

Community and Hospital Surveillance

Summary: Low activity

Alberta Health. Seasonal Influenza in Alberta. 2012/2013 Season. Surveillance and Assessment Branch. November Government of Alberta 1

Seasonal Influenza Report

Seasonal Influenza Report

Influenza Situation Update

December 3 to 9, 2017 (Week 49)

Table 1: Summary of Texas Influenza (Flu) and Influenza-like Illness (ILI) Activity for the Current Week Texas Surveillance Component

Risk assessment of seasonal influenza - Update, EU/EEA, January 2017

Summary: Decreasing. Since Sept. 1, 2017: Hospitalizations: 363 ICU* admissions: 26 Deaths: 32

Influenza Situation Update

Summary: Increasing Activity

Centers for Disease Control and Prevention U.S. INFLUENZA SEASON SUMMARY*

Summary: High Activity

MEETING THE STANDARDS: FDA MANDATORY RAPID INFLUENZA DETECTION TEST (RIDTs) RECLASSIFICATION

Week 11 (Mar.13 19, 2016)

Summary: High Activity

Global Influenza Virus Surveillance and WHO Influenza Vaccine Virus Recommendations for the Northern Hemisphere Influenza Season

Main conclusions and options for response

Austin Public Health Epidemiology and Disease Surveillance Unit. Travis County Influenza Surveillance

Low Influenza Activity

Summary: Sustained Influenza B Activity


Next report date: May 27 (May 8 21)

Summary: Low and Decreasing Activity

GIHSN-China s experience & Results of season Beijing, China

MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH WEEKLY INFLUENZA UPDATE January 4, 2019

Influenza Situation Update

Influenza Activity Update

Update on influenza monitoring and vaccine development

Week 43 (Oct , 2016)

British Columbia Influenza Surveillance Bulletin

Manitoba Health, Healthy Living and Seniors (MHHLS) Week 9 (Feb.28 Mar.5, 2016) == Severe outcomes associated with. == Cases and cumulative incidence

Influenza at the human-animal interface

Influenza Surveillance in Ireland Weekly Report Influenza Week (12 th 18 th November 2018)

Influenza Update N 176

Influenza Surveillance in Ireland Weekly Report Influenza Week (1 st 7 th October 2018)

Ontario Respiratory Pathogen Bulletin I

Local Influenza Surveillance Bulletin Released October 31, 2016

Annual Epidemiological Report DRAFT

British Columbia Influenza Surveillance Bulletin Influenza Season , Number 23, Weeks August 13 to September 23, 2017

Decreasing Activity. Since Sept. 1, 2018: Hospitalizations: 93 ICU* admissions: 16 Deaths: 5. Syndromic in Community Syndromic in Care Syndromic in ED

Influenza Weekly Surveillance Bulletin

Texas Influenza Summary Report, Season (September 28, 2008 April 11, 2009)

WEEKLY INFLUENZA REPORT

HO Global Influenza Program: Human-Animal Interface Team) PAI Activities FAO/OIE/WHO Tripartite Animal Health Meeting.

Update on Influenza Vaccines, the Influenza Season, and the Impact of Vaccination on Influenza Disease Burden

RAPID RISK ASSESSMENT. Risk assessment of seasonal influenza, EU/EEA, Conclusions and options for response. Update, 25 January 2017

OIE Situation Report for Avian Influenza

Flu Watch. MMWR Week 4: January 21 to January 27, and Deaths. Virologic Surveillance. Influenza-Like Illness Surveillance

WEEKLY INFLUENZA REPORT

Alberta Health. Seasonal Influenza in Alberta. 2016/2017 Season. Analytics and Performance Reporting Branch

Incorporating virologic data into seasonal and pandemic influenza vaccines

ONTARIO RESPIRATORY PATHOGEN BULLETIN. Assessment of Influenza Activity in Ontario

Bi-weekly Influenza Situation Update

Influenza Prevention Update

Avian Influenza A(H7N9) 13 February 2014 Surveillance Update

Transcription:

Chinese Influenza Weekly Report (All data are preliminary and may change as more reports are received) Summary During week 27, influenza activity level in mainland China was very low, only a few influenza viruses can be detected in the southern provinces, the majority were A(H1N1)pdm09, and there was few influenza virus detected in the northern provinces. Among influenza viruses antigenically characterized by CNIC since October 1 st, 2017, 628(95.4%) influenza A(H1N1)pdm09 viruses were characterized as A/Michigan/45/2015-like; 116(31.8%) influenza A(H3N2) viruses were characterized as A/Hong Kong/4801/2014 (H3N2)(EGG)-like, 330(90.4%) influenza A(H3N2) viruses were characterized as A/Hong Kong/4801/2014 (H3N2)(CELL)-like; 154(59.9%) influenza B/Victoria viruses were characterized as B/Brisbane/60/2008-like; 832(97.4%) influenza B/Yamagata viruses were characterized as B/Phuket/3073/2013-like. Among the influenza viruses tested by CNIC for antiviral resistance analysis since October 1 st, 2017, all influenza A(H1N1)pdm09 and A(H3N2) viruses were resistant to adamantine; All influenza A(H3N2) and B viruses were sensitive to neuraminidase inhibitors. All but 2 influenza A(H1N1)pdm09 were sensitive to neuraminidase inhibitors. 1

Outbreak Surveillance During week 27(July 2 nd July 8 th, 2018), there was 1 outbreak reported nationwide, the result of this one is negative. Surveillance of outpatient or emergency visits for Influenza-like Illness (ILI) During week 27, the percentage of outpatient or emergency visits for ILI (ILI %) at national sentinel hospitals in southern provinces was 3.3%, lower than the last week (3.7%) and the same week of 2015-2016 and 2017-2018(3.9%,4.1%), same as the same week of 2016-2017(2.3%). (Figure 1) Figure 1. Percentage of Visits for ILI at Sentinel Hospitalsin Southern Provinces (2015-2019) During week 27, ILI% at national sentinel hospitals in northern provinces was 2.3%, same as the last week(2.3%),lower than the same week of 2015-2016 and 2017-2018( both 2.5%), same as the same week of 2016-2017(2.3%). (Figure 2) 2

Figure 2. Percentage of Visits for ILI at Sentinel Hospitals in Northern Provinces (2015-2019) Virologic Surveillance During week 27, influenza network laboratories tested 4127 specimens, of which 45(1.1%) were positive for influenza, influenza A and influenza B viruses were 30(66.7%) and 15(33.3%), respectively (Table 1). During week 27, the percentage of specimens that were tested positive for influenza in south China was 1.4%, which was slightly higher than the previous week (1.2%) (Figure 3). During week 27, the percentage of specimens that were tested positive for influenza in north China was 0.2%, which was slightly higher than the previous week (0.0%). (Figure 4). Table 1 Laboratory Detections of ILI Specimens (Week 27, 2018) Week 27 South China North China Total No. of specimens tested 3185 942 4127 No. of positive specimens (%) 43(1.4%) 2(0.2%) 45(1.1%) Influenza A 28(65.1%) 2(100%) 30(66.7%) A(H3N2) 2(7.1%) 0(0) 2(6.7%) 3

A(H1N1)pdm09 26(92.9%) 2(100%) 28(93.3%) A (subtype not determined) 0(0) 0(0) 0(0) Influenza B 15(34.9%) 0(0) 15(33.3%) B (lineage not determined) 0(0) 0(0) 0(0) Victoria 5(33.3%) 0(0) 5(33.3%) Yamagata 10(66.7%) 0(0) 10(66.7%) Figure 3. Influenza Positive Tests Reported by Southern Network Laboratories (Week 14, 2017 Week 27, 2018) Note: Analysis in this part was based on the test results of network laboratories. If it were not consistent with the results of CNIC confirmation, the results of CNIC confirmation were used. 4

Figure 4. Influenza Positive Tests Reported by Northern Network Laboratories (Week 14, 2017 Week 27, 2018) Note: Analysis in this part was based on the result of network laboratories. If it were not consistent with the results of CNIC confirmation, the results of CNIC confirmation were used. Antigenic Characterization Since October 1 st, 2017, 628(95.4%) influenza A(H1N1)pdm09 viruses were characterized as A/Michigan/45/2015-like; 116(31.8%) influenza A(H3N2) viruses were characterized as A/Hong Kong/4801/2014 (H3N2)(EGG)-like, 330(90.4%) influenza A(H3N2) viruses were characterized as A/Hong Kong/4801/2014 (H3N2)(CELL)-like; 154(59.9%) influenza B/Victoria viruses were characterized as B/Brisbane/60/2008-like; 832(97.4%) influenza B/Yamagata viruses were characterized as B/Phuket/3073/2013-like. Antiviral Resistance Since October 1 st, 2017, among the influenza viruses tested by CNIC for antiviral resistance, all influenza A(H1N1)pdm09 and A(H3N2) viruses were resistant to adamantine; All influenza A(H3N2) and B viruses were sensitive to neuraminidase inhibitors. All but 2 influenza A(H1N1)pdm09 were sensitive to neuraminidase inhibitors. H7N9 case report 5

Since the notification of human infection with novel reassortant influenza A(H7N9) virus on 31 March 2013, in total 1564 laboratory-confirmed cases have been reported to WHO. Among them, 32 cases were infected with HPAI A(H7N9) virus, which have mutations in the hemagglutin in gene indicating a change to high pathogenicity in poultry. These 32 cases are from Taiwan (the case had travel history to Guangdong), Guangxi, Guangdong, Hunan, Shaanxi, Hebei, Henan, Fujian, Yunnan provinces, with illness onset date before October 2017. No increased transmissibility or virulence to human case was detected in the HPAI A(H7N9) virus. 6